Elena Lanati
Founder
Lionhealth
Lionhealth develops specialized medical foods (AFMS) focused on clinical nutrition for specific pathologies. The company combines scientific research, plant extracts, and ESG principles to address and prevent caloric-protein malnutrition in patients. Their product line aims to help individuals maintain or recover normal nutritional status associated with their underlying conditions.
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Maria Cafiero
Founder
Alberto Vaudano
Founder
Product
Problem
Patients with chronic diseases often experience disease-related malnutrition (DRM), leading to muscle mass loss, reduced physical function, and poorer clinical outcomes. Current nutritional support strategies may not adequately address the specific metabolic and physiological needs of individuals with diverse chronic conditions.
Solution
Lionhealth develops disease-specific Foods for Special Medical Purposes (FSMPs) designed to manage caloric-protein malnutrition in patients with chronic inflammatory bowel disease (IBD), oncology, rare diseases, and central nervous system disorders. Our products integrate scientific research, patented plant extracts, and adhere to Environmental, Social, and Governance (ESG) principles. By providing targeted nutritional interventions, Lionhealth aims to help patients maintain or recover their nutritional status and improve overall health outcomes.
Target Audience
Our primary customers are healthcare professionals, including gastroenterologists, oncologists, and dietitians, who manage patients with chronic diseases and associated malnutrition. We also target hospital networks and specialized clinics requiring advanced nutritional support solutions.
Features
- FSMPs formulated to meet specific nutritional requirements for various disease states, including IBD, oncology, and neurological conditions.
- Products incorporate proprietary matrices containing scientifically validated plant extracts and essential nutrients.
- Formulations are developed in collaboration with leading experts and adhere to international clinical nutrition guidelines, such as ESPEN MICI guidelines.
- High-protein formulations designed to address sarcopenia and support perioperative phases.
- Products are developed and manufactured in Italy, emphasizing a commitment to quality and an Italian supply chain.
- Commitment to ESG principles, including supply chain sustainability and carbon footprint neutralization.
- Specific product example: LH Viola, a high-protein FSMP for IBD patients, formulated with plant extracts, Vitamin D3, and B12, and designed for patient compliance with a neutral taste and versatile mixing options.